CDC Survey Finds 1 in 10 Adults Used GLP-1s Past Year
A CDC Morbidity and Mortality Weekly Report published Nov. 12, based on a survey of 8,118 adults collected in July and August 2025, found 9.8% of U.S. adults reported GLP-1 medication use in the past year, rising to 47.4% among adults with diabetes and 24.1% among those with severe obesity. Use was higher among women than men and among adults 40 and older than those 18 to 39. Among users, 22.6% reported taking a compounded version not reviewed by the FDA for safety, effectiveness or quality, with compounded use higher among those with private insurance than public insurance. About 44% of users modified their use from how it was prescribed, most commonly by skipping doses, with 38% of those who modified citing cost and 36% citing availability; cost was cited by 58% of users ages 18 to 39 versus 20% of those 65 and older.